Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Hemoglobin ; 39(1): 36-41, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25395219

RESUMO

Abstract ß-Thalassemia (ß-thal) is a genetic disorder, representing a major health problem in Algeria. It is associated with altered lipid levels and a state of oxidative stress that can lead to cardiac complications and premature death. We examined the plasma lipid profile and redox status of 46 patients with ß-thal major (ß-TM) and ß-thal intermedia (ß-TI) compared to 36 healthy subjects. Plasma lipids including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were investigated. Oxidative status was evaluated by measuring malondialdehyde (MDA), reduced glutathione (GSH) and catalase (CAT) activity. The potential relationships between these parameters and the hemoglobin (Hb) blood concentrations, serum ferritin, duration and frequency of transfusion, splenectomy as well as age, were examined. Our data indicated that the study patients were under increased state of oxidative stress associated with hypertriglyceridemia, and hypocholesterolemia. The CAT activity was negatively correlated with Hb concentration and LDL-C/TG ratio and positively with years of transfusion. The elevated TC/HDL-C ratio particularly in ß-TM patients who were younger, correlated positively with ferritinemia and triglyceride levels and suggested an increased coronary risk. This heightened risk state should lead to the inclusion of this index (TC/HDL-C) in clinical management, particularly in splenectomized patients.


Assuntos
Metabolismo dos Lipídeos , Lipídeos/sangue , Estresse Oxidativo , Talassemia beta/sangue , Talassemia beta/metabolismo , Adolescente , Adulto , Catalase/sangue , Catalase/metabolismo , Feminino , Glutationa/sangue , Glutationa/metabolismo , Humanos , Masculino , Malondialdeído/sangue , Malondialdeído/metabolismo , Oxirredução , Adulto Jovem , Talassemia beta/complicações
2.
Hemoglobin ; 33(1): 24-36, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19205970

RESUMO

This study concerns the molecular characterization of beta-thalassemia (beta-thal) alleles in 210 chromosomes. In the studied population, mutations were detected in 98% of the beta-thalassemic chromosomes. Twenty-one molecular defects have been found, where the five dominant mutations, IVS-I-110 (G>A), nonsense mutation at codon 39 (C>T), the frameshift codon (FSC) 6 (-A), IVS-I-1 (G>A), and IVS-I-6 (T>C), account for 80% of the independent chromosomes. Among the remaining alleles, 16 different mutations were identified, half of them being described for the first time in Algeria. These include the -101 (C>T) and the -90 (C>T) mutations in the distal and proximal promoter elements, respectively, the FSC 8 (-AA), IVS-I-5 (G>T), IVS-I-128 (T>G), FSC 47 (+A), IVS-II-1 (G>A), and the substitution in the polyadenylation signal (poly A) site AATAAA>AATGAA. Haplotype analyses on rare variants were performed. The possible origin of these mutations either by founder effect or by migrations is discussed, and raises the question of an adequate strategy to be used adapted to socio-economical status.


Assuntos
Heterogeneidade Genética , Mutação , Talassemia beta/genética , Argélia/epidemiologia , Alelos , Cromossomos Humanos , Análise Mutacional de DNA , Emigração e Imigração , Efeito Fundador , Humanos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa